Molecular & evolutionary genetics & drug resistance of the gastric pathogen, Helicobacter pylori. 2002

S Datta, and A Chowdhury, and A K Mukhopadhyay, and S K Bhattacharya, and D E Berg, and G B Nair
National Institute of Cholera & Enteric Diseases (ICMR), Institute of Post Graduate Medical Education & Research, Kolkata, India.

Helicobacter pylori colonizes the gastric mucosa of more than half of all people worldwide and is the major cause of peptic ulcer disease and an early risk factor for gastric cancer, even though most infections are asymptomatic. Infection occurs preferentially in early childhood and once established tends to persist for years or decades. Much of the pathology H. pylori causes probably results from the host response to infection, which is affected by bacterial genotype, human host characteristics and environmental conditions. H. pylori is one of the most genetically diverse of bacterial species, with different genotypes predominating in different parts of the world. In particular, strains from India differ from those of Europe and East Asia in DNA sequence of several diagnostic gene segments. This outcome invites speculation about H. pylori origins and the possibility of Indian-specific genes that might be uncommon in Western strains. Much has been learned from H. pylori genome sequences, along with epidemiological, mutational, molecular and immunologic analyses. Candidate bacterial colonization and virulence genes and host responses are being identified, and the hypotheses being developed are amenable to tests in cell culture and animal models. These research efforts, many of which are collaborative and international, provide insights into mechanisms of establishment and persistence of H. pylori infection and virulence, and should lead to new, far more potent and cost effective anti-Helicobacter therapies or vaccines, and thereby major improvement in human health worldwide.

UI MeSH Term Description Entries
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D016480 Helicobacter pylori A spiral bacterium active as a human gastric pathogen. It is a gram-negative, urease-positive, curved or slightly spiral organism initially isolated in 1982 from patients with lesions of gastritis or peptic ulcers in Western Australia. Helicobacter pylori was originally classified in the genus CAMPYLOBACTER, but RNA sequencing, cellular fatty acid profiles, growth patterns, and other taxonomic characteristics indicate that the micro-organism should be included in the genus HELICOBACTER. It has been officially transferred to Helicobacter gen. nov. (see Int J Syst Bacteriol 1989 Oct;39(4):297-405). Campylobacter pylori,Campylobacter pylori subsp. pylori,Campylobacter pyloridis,Helicobacter nemestrinae
D019143 Evolution, Molecular The process of cumulative change at the level of DNA; RNA; and PROTEINS, over successive generations. Molecular Evolution,Genetic Evolution,Evolution, Genetic

Related Publications

S Datta, and A Chowdhury, and A K Mukhopadhyay, and S K Bhattacharya, and D E Berg, and G B Nair
October 2017, Nature reviews. Genetics,
S Datta, and A Chowdhury, and A K Mukhopadhyay, and S K Bhattacharya, and D E Berg, and G B Nair
January 2014, Frontiers in medicine,
S Datta, and A Chowdhury, and A K Mukhopadhyay, and S K Bhattacharya, and D E Berg, and G B Nair
April 2001, Archives of pathology & laboratory medicine,
S Datta, and A Chowdhury, and A K Mukhopadhyay, and S K Bhattacharya, and D E Berg, and G B Nair
January 2021, Frontiers in microbiology,
S Datta, and A Chowdhury, and A K Mukhopadhyay, and S K Bhattacharya, and D E Berg, and G B Nair
April 2014, Journal of gastroenterology,
S Datta, and A Chowdhury, and A K Mukhopadhyay, and S K Bhattacharya, and D E Berg, and G B Nair
January 2016, Arquivos de gastroenterologia,
S Datta, and A Chowdhury, and A K Mukhopadhyay, and S K Bhattacharya, and D E Berg, and G B Nair
January 2016, Arquivos de gastroenterologia,
S Datta, and A Chowdhury, and A K Mukhopadhyay, and S K Bhattacharya, and D E Berg, and G B Nair
January 1995, JPMA. The Journal of the Pakistan Medical Association,
S Datta, and A Chowdhury, and A K Mukhopadhyay, and S K Bhattacharya, and D E Berg, and G B Nair
August 1997, Nature,
S Datta, and A Chowdhury, and A K Mukhopadhyay, and S K Bhattacharya, and D E Berg, and G B Nair
February 2014, Nucleic acids research,
Copied contents to your clipboard!